AU2018428571B2 - Lactobacillus plantarum compositions and uses thereof - Google Patents

Lactobacillus plantarum compositions and uses thereof

Info

Publication number
AU2018428571B2
AU2018428571B2 AU2018428571A AU2018428571A AU2018428571B2 AU 2018428571 B2 AU2018428571 B2 AU 2018428571B2 AU 2018428571 A AU2018428571 A AU 2018428571A AU 2018428571 A AU2018428571 A AU 2018428571A AU 2018428571 B2 AU2018428571 B2 AU 2018428571B2
Authority
AU
Australia
Prior art keywords
compositions
lactobacillus plantarum
plantarum
lactobacillus
plantarum compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018428571A
Other languages
English (en)
Other versions
AU2018428571A1 (en
Inventor
Bengt Jeppsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi AB filed Critical Probi AB
Publication of AU2018428571A1 publication Critical patent/AU2018428571A1/en
Application granted granted Critical
Publication of AU2018428571B2 publication Critical patent/AU2018428571B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pediatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2018428571A 2018-06-18 2018-06-18 Lactobacillus plantarum compositions and uses thereof Active AU2018428571B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/066154 WO2019242839A1 (en) 2018-06-18 2018-06-18 Lactobacillus plantarum compositions and uses thereof

Publications (2)

Publication Number Publication Date
AU2018428571A1 AU2018428571A1 (en) 2021-01-28
AU2018428571B2 true AU2018428571B2 (en) 2025-06-26

Family

ID=62842054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018428571A Active AU2018428571B2 (en) 2018-06-18 2018-06-18 Lactobacillus plantarum compositions and uses thereof

Country Status (12)

Country Link
US (1) US12558385B2 (enExample)
EP (1) EP3806876B1 (enExample)
JP (1) JP7476183B2 (enExample)
KR (1) KR102770563B1 (enExample)
CN (1) CN112638393B (enExample)
AU (1) AU2018428571B2 (enExample)
BR (1) BR112020026076A2 (enExample)
CA (1) CA3102445A1 (enExample)
ES (1) ES2966935T3 (enExample)
MX (1) MX2020013860A (enExample)
PL (1) PL3806876T3 (enExample)
WO (2) WO2019242839A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018428571B2 (en) 2018-06-18 2025-06-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3011322A1 (en) * 2016-01-19 2017-07-27 Probi Ab Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100979877B1 (ko) 2001-09-28 2010-09-02 뉴트라슈틱스 인코포레이티드 생물학적 성분의 전달 시스템
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
KR101300086B1 (ko) 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
ZA200802934B (en) 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
SE533778C2 (sv) * 2009-05-14 2011-01-11 Probi Ab Probiotisk fruktdryck
KR102129934B1 (ko) 2013-04-03 2020-07-03 프로비 아베 골다공증의 치료 또는 예방에 사용되는 프로바이오틱 스트레인
EP3164145A4 (en) 2014-07-01 2018-01-17 Probi Usa, Inc. Bi-layer dual release probiotic tablets
WO2017060477A1 (en) 2015-10-07 2017-04-13 Bifodan A/S Probiotic formulation
GB201708932D0 (en) 2017-06-05 2017-07-19 Probi Ab Microbial compositions
AU2018428571B2 (en) 2018-06-18 2025-06-26 Probi Ab Lactobacillus plantarum compositions and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3011322A1 (en) * 2016-01-19 2017-07-27 Probi Ab Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JIN-JU JEONG ET AL, PLOS ONE, vol. 10, no. 2, 17 February 2015 (2015-02-17), pages e0116533, DOI: 10.1371/journal.pone.0116533 *
VILAHUR GEMMA ET AL, EUROPEAN JOURNAL OF NUTRITION, STEINKOPFF VERLAG, DARMSTADT, DE, vol. 54, no. 7, 19 November 2014 (2014-11-19), pages 1161 - 1171, DOI: 10.1007/S00394-014-0794-9 *

Also Published As

Publication number Publication date
PL3806876T3 (pl) 2024-03-25
EP3806876B1 (en) 2023-09-20
MX2020013860A (es) 2021-03-25
CN112638393A (zh) 2021-04-09
EP3806876A1 (en) 2021-04-21
KR20210023972A (ko) 2021-03-04
WO2019243169A1 (en) 2019-12-26
CN112638393B (zh) 2024-07-26
US20210154248A1 (en) 2021-05-27
CA3102445A1 (en) 2019-12-26
JP2021527718A (ja) 2021-10-14
ES2966935T3 (es) 2024-04-25
US12558385B2 (en) 2026-02-24
BR112020026076A2 (pt) 2021-03-23
WO2019242839A1 (en) 2019-12-26
KR102770563B1 (ko) 2025-02-21
EP3806876C0 (en) 2023-09-20
JP7476183B2 (ja) 2024-04-30
AU2018428571A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
EP3620513A4 (en) COMPOSITION CONSISTING OF STRAINS CJLP475 OF LACTOBACILLUS PLANTARUM AND CJLP243 OF LACTOBACILLUS PLANTARUM, AND ASSOCIATED USE
GB201905386D0 (en) Probiotic compositions and uses thereof
EP4051017A4 (en) PROBIOTIC COMPOSITIONS AND METHODS
PL3806876T3 (pl) Kompozycje z lactobacillus plantarum i ich zastosowanie
GB201908154D0 (en) Lactobacillus compositions and uses thereof
IL284120A (en) Ready-to-use and used probiotic compounds
GB201908706D0 (en) Lactobacillus compositions and uses thereof
AU2019903291A0 (en) Probiotic compositions and uses thereof
AU2018903305A0 (en) Probiotic compositions and uses thereof (II)
GB201905389D0 (en) Probiotic compositions and uses
AU2018903306A0 (en) Probiotic compositions and uses thereof (I)
GB201809947D0 (en) Probiotic compositions and uses thereof
HK40049539A (en) Senolytic compositions and uses thereof
HK40048040A (en) Fusosome compositions and uses thereof
HK40045690A (en) Fusosome compositions and uses thereof
AU2019904921A0 (en) Compositions and uses thereof
AU2019904920A0 (en) Compositions and uses thereof
AU2019904813A0 (en) Compositions and uses thereof
HK40044873A (en) Erenumab compositions and uses thereof
HK40062246A (en) Engineered flagellin-derived compositions and uses
AU2017903563A0 (en) Probiotic compositions and uses thereof (II)
AU2019903417A0 (en) Compositions and uses thereof
AU2018904330A0 (en) Compositions and uses thereof
AU2019903692A0 (en) Composition and uses thereof
AU2017903564A0 (en) Probiotic compositions and uses thereof (I)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)